arcadia

DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE2800.90-24.9 (-0.88 %)
PREV CLOSE ( ) 2825.80
OPEN PRICE ( ) 2819.95
BID PRICE (QTY) 2804.00 (10)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9017
TODAY'S LOW / HIGH ( )2792.70 2826.00
52 WK LOW / HIGH ( )1888 2875
NSE2799.10-26 (-0.92 %)
PREV CLOSE( ) 2825.10
OPEN PRICE ( ) 2827.95
BID PRICE (QTY) 2799.10 (24)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 433608
TODAY'S LOW / HIGH( ) 2791.35 2827.95
52 WK LOW / HIGH ( )1872.95 2878
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 24-02 1984
Management Info
K Satish Reddy - Chairman GV Prasad - Managing Director
Registered Office

Address 8-2-337, Road No. 3,Banjara Hills,,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email sureshvs@drreddys.com ; shares@drreddys.com

Website www.drreddys.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York
NEWS
16Apr Dr. Reddys Lab, Majesco and Cipla to s
Dr. Reddys Laboratories has received the Establishment Inspection Report..
16Apr Dr. Reddys Lab receives EIR from USFDA
Dr. Reddys Laboratories has received the Establishment Inspection Report..
15Apr Dr. Reddy's Lab to acquire portfolio o
Dr. Reddy's Laboratories has entered into a definitive agreement to acqu..
02Apr Dr. Reddy’s Laboratories’ arm declares
Dr. Reddy’s Laboratories through its wholly owned subsidiary -- Promius..
02Apr Dr. Reddy’s Laboratories enters into c
Dr. Reddy’s Laboratories has entered into a confidential settlement agre..
Financials
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit39945669
Gross Profit 5704 6970
Operating Profit 779715339
Net Sales 2731793593
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Hester Biosciences (BSE)
 1487.50 (2.00%)
M.Cap ( in Cr)1265.40
Ipca Laboratories (BSE)
 968.95 (2.98%)
M.Cap ( in Cr)12242.89
Shilpa Medicare (BSE)
 398.70 (5.98%)
M.Cap ( in Cr)3250.48
Fredun Pharma (BSE)
 473.35 (3.60%)
M.Cap ( in Cr)188.85
Themis Medicare (BSE)
 297.45 (3.59%)
M.Cap ( in Cr)273.09
Shareholding Pattern
PROMOTERS 26.77%
NON-INSTITUTION 13.66%
MUTUAL FUNDS/UTI 9.11%
FI/BANKS/INSURANCE 5.13%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM